BPC-157 + TB-500 (5 mg + 5 mg)

BPC-157 + TB-500 (5 mg + 5 mg) — Research Overview

A half-strength presentation of the BPC-157 and TB-500 pairing, supplied as 5 mg of each peptide in a single vial. The lower loading suits shorter research protocols, pilot work, and dose-ranging studies where a full 10 mg + 10 mg vial would exceed the quantity required.

Mechanism & Research Applications

BPC-157 is investigated for angiogenic signalling and growth factor pathways; TB-500, a synthetic fragment of thymosin beta-4, is investigated for actin sequestration and the cell migration that follows. Because the two act at different points in the tissue-repair sequence, they are frequently studied together rather than in isolation.

Supplying both in one pre-combined vial removes a reconstitution step and keeps the ratio between components fixed across a study — useful when comparative consistency between runs matters more than independent dosing.

Specifications

BPC-157 5 mg + TB-500 5 mg | ≥99% purity per component (HPLC-verified) | Batch-specific COA included

Quality & Sourcing in Canada

NuMe supplies this blend alongside the 10 mg + 10 mg presentation as part of its catalogue of healing peptides in Canada. Every batch is verified to ≥99% purity by HPLC and ships with a batch-specific Certificate of Analysis.

For Research Purposes Only.